The Treatment of Verrucae Pedis Using Falknor’s Needling Method: A Review of 46 Cases
AbstractHuman Papilloma Virus (HPV) related verrucae pedis persist, seemingly evading host immune surveillance, yet sometimes disappear with inflammation. The absence, or reduction, of a cellular immune response may explain why verrucae treatments are not uniformly successful and treatment can be difficult even in immune-competent individuals. Little investigation has been undertaken into the potential benefit and efficacy of needling verrucae, a treatment modality causing HPV infected keratinocyte destruction in addition to inducing an assumed enhanced immune response. A review of clinical practice is presented, reporting the treatment method and results of data collected from a retrospective review of 45 patients. Thirty-one (69%) cases demonstrated complete resolution of verrucae following needling treatment. Three patients demonstrated reduction in size and pain whilst 11 showed no improvement. No adverse events were noted. Needling may have a place in the management of verrucae pedis in an adult population but a large scale study utilising objective measures and a control intervention would provide more detailed efficacy data along with a greater understanding of the effects of this treatment on long term immunity.
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Longhurst, B.; Bristow, I. The Treatment of Verrucae Pedis Using Falknor’s Needling Method: A Review of 46 Cases. J. Clin. Med. 2013, 2, 13-21.
Longhurst B, Bristow I. The Treatment of Verrucae Pedis Using Falknor’s Needling Method: A Review of 46 Cases. Journal of Clinical Medicine. 2013; 2(2):13-21.Chicago/Turabian Style
Longhurst, Belinda; Bristow, Ivan. 2013. "The Treatment of Verrucae Pedis Using Falknor’s Needling Method: A Review of 46 Cases." J. Clin. Med. 2, no. 2: 13-21.